Financhill
Back

Aytu BioPharma Stock Predictions

Aytu BioPharma Stock Forecast

  • Is Aytu BioPharma Stock Undervalued?
    The current Aytu BioPharma [AYTU] share price is $1.55. The Score for AYTU is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • AYTU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Aytu BioPharma Stock Go Up Next Year?

Data Unavailable

Aytu BioPharma Stock Rating

Data Unavailable

Aytu BioPharma Stock Price History

Is AYTU stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AYTU is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
aytubio.com

52-Week Data

52-Week High:
3.45
52-Week Low:
1.49

Prediction Charts

Market Cap:
9.53M
Price in USD:
1.55
Volume:
63.7K
Beta:
0.10

Technical Analysis

SMA50:
2.21
SMA100:
2.43
SMA200:
2.71
52-Wk Change:
-32.31%

Stock Predictions

  • Is Aytu BioPharma stock public?
    Yes, Aytu BioPharma is a publicly traded company.
  • What is the Aytu BioPharma stock quote today?
    The Aytu BioPharma stock price is 1.55 USD today.
  • How to buy Aytu BioPharma stock online?
    You can buy Aytu BioPharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 2.10 2.00 2.15 1.95
Oct-30 2.00 1.99 2.09 1.97
Oct-31 1.96 1.92 1.97 1.90
Nov-1 2.01 1.94 2.03 1.91
Nov-4 1.91 1.91 2.04 1.90
Nov-5 1.97 1.85 2.23 1.83
Nov-6 1.85 1.84 2.01 1.81
Nov-7 1.81 1.82 1.90 1.77
Nov-8 1.70 1.64 1.93 1.60
Nov-11 1.74 1.77 1.88 1.72
Nov-12 1.80 1.74 1.97 1.67
Nov-13 1.80 1.75 1.86 1.68
Nov-14 1.72 1.55 1.77 1.49
Nov-15 1.62 1.55 1.76 1.50

Aytu BioPharma Earnings

Data Unavailable

Aytu BioPharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.44 per share, and a decrease next year of $0.00 per share.

* Aytu BioPharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.